James H. Berry, DO

Recent Publications

2023

Mahoney JJ, Haut MW, Carpenter J, Ranjan M, Thompson-Lake DGY, Marton JL, Zheng W, Berry JH, Tirumalai P, Mears A, D’Haese P, Finomore VS, Hodder SL, Rezai AR. Low-intensity focused ultrasound targeting the nucleus accumbens as a potential treatment for substance use disorder: safety and feasibility clinical trial. Frontiers in Psychiatry 2023;14. DOI: 10.3389/fpsyt.2023.1211566

Mahoney JJ 3rd, Thompson-Lake DGY, Ranjan M, Marton JL, Carpenter JS, Zheng W, Berry JH, Farmer DL, D'Haese P, Finomore VS, Tirumalai P, Mears AS, Suffridge J, Ames A, Hodder SL, Rezai AR. Low-Intensity Focused Ultrasound Targeting the Bilateral Nucleus Accumbens as a Potential Treatment for Substance Use Disorder: A First-in-Human Report. Biol Psychiatry 2023. Epub ahead of print. PMID: 37610405. DOI: 10.1016/j.biopsych.2023.06.031

Rezai AR, Mahoney JJ, Ranjan M, Haut MW, Zheng W, Lander LR, Berry JH, Farmer DL, Marton JL, Tirumalai P, Mears A, Thompson-Lake DGY, Finomore VS, D'Haese PF, Aklin WM, George DT, Corrigan JD, Hodder SL. Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder. Journal of Neurosurgery 2023:1-9. Epub ahead of print. PMID: 37329519. DOI: 10.3171/2023.4.JNS23114

van Oppen D, Zell M, Berry J. Opioid Use Disorder. In: Encyclopedia of the Neurological Sciences, third edition. Published online in: Reference Module in Neuroscience and Biobehavioral Psychology, Elsevier 2023. DOI: 10.1016/B978-0-323-95702-1.00028-2

2022

Felicione NJ, Ozga JE, Dino G, Berry JH, Sullivan CR, Blank MD. Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial. J Subst Abuse Treat 2022;132:108579. PMID: 34452780. PMCID: PMC8671242. DOI: 10.1016/j.jsat.2021.108579

Mahoney JJ 3rd, Koch-Gallup N, Scarisbrick DM, Berry JH, Rezai AR. Deep brain stimulation for psychiatric disorders and behavioral/cognitive-related indications: Review of the literature and implications for treatment. J Neurol Sci 2022;437:120253. PMID: 35460949. DOI: 10.1016/j.jns.2022.120253

Rockett IRH, Jia H, Ali B, Banerjee A, Connery HS, Nolte KB, Miller T, White FMM, DiGregorio BD, Larkin GL, Stack S, Kõlves K, McHugh RK, Lulla VO, Cossman J, De Leo D, Hendricks B, Nestadt PS, Berry JH, D'Onofrio G, Caine ED. Association of State Social and Environmental Factors With Rates of Self-injury Mortality and Suicide in the United States. JAMA Netw Open 2022;5(2):e2146591. PMID: 35138401. PMCID: PMC8829661. DOI: 10.1001/jamanetworkopen.2021

Winstanley EL, Thacker EP, Choo LY, Lander LR, Berry JH, Tofighi B. Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use. Drug and Alcohol Dependence Reports 2022;5:100091. DOI: 10.1016/j.dadr.2022.100091

2021

Aboraya A, Nasrallah HA, Elswick D, Rastgar Y, Berry J, Hill C, Justice J, Zheng W, Pearson N, Gallucci G, Figgs P, Hustead J, Vogt J, Zafar J, Dohar S, Looper R, Guinan D, Elawady A, Shah O, Lam MW, Shagufta S, Schwartzman N, Hamric E, Mayle L, Miller M, Chandran D, Marshalek P, Moreland R, Tamang TL, Mattancheril S, Berzingi S. Measurement-based care training curriculum in psychiatry residency programs: I: Description of the curriculum and demonstration of implementation. Ann Clin Psychiatry 2021;33(3):168-179. PMID: 34398732. DOI: 10.12788/acp.0039

Mahoney JJ, Haut MW, Hodder SL, Zheng W, Lander LR, Berry JH, Farmer DL, Marton JL, Ranjan M, Brandmeir NJ, Finomore VS, Hensley JL, Aklin WM, Wang GJ, Tomasi D, Shokri-Kojori E, Rezai AR. Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder. Experimental and Clinical Psychopharmacology 2021;29(2):210-5. PMID: 34043402. DOI: 10.1037/pha0000453

Mahoney JJ, Winstanley EL, Lander LR, Berry JH, Marshalek PJ, Haut MW, Marton JL, Kimble WD, Armistead, Wen S, Cai Y, Hodder SL. High prevalence of co-occurring substance use in individuals with opioid use disorder. Addictive Behaviors 2021;114:106752. PMID: 33348147. DOI: 10.1016/j.addbeh.2020.106752

Rockett IRH, Caine ED, Banerjee A, Ali B, Miller T, Connery HS, Lulla VO, Nolte KB, Larkin GL, Stack S, Hendricks B, McHugh RK, White FMM, Greenfield SF, Bohnert ASB, Cossman JS, D'Onofrio G, Nelson LS, Nestadt PS, Berry JH, Jia H. Fatal self-injury in the United States, 1999-2018: Unmasking a national mental health crisis. EClinicalMedicine 2021;32:100741. PMID: 33681743. PMCID: PMC7910714. DOI: 10.1016/j.eclinm.2021.100741

Tacker DH, Adelanwa A, Pearson N, Marshalek P, Berry JH. Fentanyl Quality Assurance Project Prompted Change in Clinical Workflow and Test Configurations. J Appl Lab Med 2021;6(1):93-100. PMID: 33276372. PMCID: PMC8415574. DOI: 10.1093/jalm/jfaa173

Winstanley EL, Lander LR, Zheng W, Law KB, Six-Workman A, Berry JH. Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19. Journal of Addiction Medicine 2021;15(3):263-265. PMID: 33105168. DOI:10.1097/ADM.0000000000000748

“Opioid Withdrawal” in The SAGE Encyclopedia of Abnormal and Clinical Psychology Berry JH, Sullivan CR. New York, NY: SAGE Publications 2017

The ADA Practical Guide to Substance Use Disorders and Safe Prescribing, Chapter 2 Understanding the Disease of Substance Use Disorders; James H. Berry, DO & Carl R. Sullivan, MD, FACP; Mile O’Neil PhD, editor; Wiley Publishing (at editors, Publish date August 1, 2015)

Substances of Abuse and Their Clinical Implications Berry J., Sullivan CR, Kmiec J, Douaihy A;, Chapter 5 Substance Use Disorders, Pittsburgh Pocket Psychiatry eds: Douaihy A, Daley D; Oxford University Press, 2014.

14th International Congress on Schizophrenia Research. Orlando, FL. April 21-25, 2013. Abstract Title: Assessment of Schizophrenia using the dimensional component of the Standard for Clinicians’ Interview in Psychiatry (SCIP). Authors: A. Aboraya, MD, D. Elswick, MD, J. Berry, DO, C. Hill, MD. Published in Schizophr Bull (2013) 39 (Suppl 1): S1-S358 doi:10.1093/schbul/sbt011